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Abstract:  We  present  a  noninvasive  method  of  detecting  substance 
concentration in the aqueous humor based on dual-wavelength iris imaging 
technology. Two light sources, one centered within (392 nm) and the other 
centered outside (850 nm) of an absorption band of Pirenoxine Sodium, a 
common  type  of  drugs  in  eye  disease  treatment,  were  used  for  dual-
wavelength iris imaging measurement. After passing through the aqueous 
humor twice, the back-scattering light  was detected by a charge-coupled 
device  (CCD).  The  detected  images  were  then  used  to  calculate  the 
concentration of Pirenoxine Sodium. In eye model experiment, a resolution 
of  0.6525  ppm  was  achieved.  Meanwhile,  at  least  4  ppm  can  be 
distinguished  in  in  vivo  experiment.  These  results  demonstrated  that  our 
method  can  measure  Pirenoxine  Sodium  concentration  in  the  aqueous 
humor and its potential ability to monitor other materials’ concentration in 
the aqueous humor. 
©2011 Optical Society of America 
OCIS  codes:  (110.2970)  Image  detection  systems;  (170.1470)  Blood  or  tissue  constituent 
monitoring; (170.3880) Medical and biological imaging; (170.4470) Ophthalmology. 
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1. Introduction 
The aqueous humor is limpid watery fluid that fills the space between the cornea and the lens 
in the eye [1,2]. It mainly consists of water, which takes up nearly 99 percents [3], as well as 
amount of glucose, proteins, ascorbate, lactate, etc. In healthy eyes, these components remain 
at a standard level. This level, however, may become irregular for people with eye disorders 
[4–6]. Moreover, since aqueous humor is formed from plasma, their compositions are almost 
the same. Each substance concentration in aqueous humor has a stable ratio to itself in blood 
[7,8]. Meanwhile, drugs to treat various eye disorders are delivered to the aqueous humor. The 
concentration  of  a  drug  in  the  aqueous  humor  directly  reflects  its  bioavailability.  The 
conventional approach to measure material concentration in the anterior chamber is to extract 
a sample of aqueous humor which is invasive. This technique is rarely used for investigation 
in human because it carries a risk of endophthalmitis. 
Noninvasive sensing approaches for substances in the aqueous humor have been proposed 
in the past several years, including spectroscopic absorption, polarization changes, Raman 
spectroscopy, iris imaging analysis, and infrared spectroscopy. In 1999, Cameron et al. [9] 
introduced a dual wavelength laser-based polarimeter to measure glucose concentration. A 
resolution glucose level of 12.8 mg/dL in the curette experiments with real-time closed-loop 
dual-wavelength optical polarimetry was reported by Malik et al. [10,11] recently. In 2002, 
Miller  et  al.  [12]  designed  a  contact  lens  to  detect  optical  absorbance  spectrum  of  drug 
compounds  minimally  invasively.  The  drugs’  spectra  in  different  concentration  can  be 
distinguished in ex vivo rabbit’s eye experiment. In 2005, Lambert et al [13], Pelletier et al. 
[14] utilized Raman spectroscopy to quantify substance concentration in the aqueous humor. 
A root-mean-square error of 22 mg/dL was achieved in artificial aqueous humor experiment. 
In 2007, Weissbrodt et al. [15] examined infrared spectroscopy of human aqueous humor and 
pointed out that eyes  with cataract, age-related  macular degeneration, or diabetic  macular 
edema can be differentiated by the method. Such researches have provided possible solutions 
to monitor substance concentration in the aqueous humor. 
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with small spot size shining onto the sample. The uncertainty of spatial positional signals has 
influence  on  the  accuracy  of  measurements.  This  influence  including  the  speckle-induced 
errors  can  be  avoided  in  the  iris  imaging  technique.  Moreover,  such  technique  can  be 
potentially  used  in  combination  with  iris  recognition  technology,  which  has  been  widely 
applied in biometrics security field at present. By adding an image processing program in 
current iris recognition system, the iris can be identified and substance concentration in the 
aqueous humor can be monitored at the same time. In 2010, a multivariate image processing 
technique was reported by Webb et al. [16] for noninvasive glucose sensing. Based on the 
refractive index change of the aqueous humor induced by glucose concentration [17], they 
created a calibration model to predict glucose concentration by analyzing iris image. 
In  this  paper,  we  report  a  method  to  detect  concentration  of  materials  with  a  dual-
wavelength iris imaging technique. According to the absorption spectrum of the material, two 
light sources with wavelengths at 392 nm and at 850 nm were selected, where the absorption 
coefficients are relatively the same for water but significantly different for Pirenoxine Sodium 
in the anterior chamber. The variations of light absorbed by the aqueous humor in the two 
wavelengths were measured from the iris images. The material concentration can therefore be 
predicted by analyzing the absorbed light. Moreover, an in vivo experiment was carried out to 
prove the feasibility of our approach. 
2. Principles 
The structure of a typical anterior chamber is shown in Fig. 1. A light beam with intensity I0 
passes through the aqueous humor in the anterior chamber of the eye. Since the cornea and the 
aqueous  humor  are  nearly  optically  non-scattering,  the  iris  could  be  treated  as  a  natural 
reflector to scatter the beam back. The intensity I of the scattered beam from the iris after 
propagating  through the aqueous  humor  with a thickness of d twice can be described by 
Beer’s law 
 
2( ( ) ( ))
0 ( , ) ( ) ,
as d I d I e
    
     (1) 
where λ is the wavelength, μa is the absorption coefficient and μs is the scattering coefficient. 
Considering the variation of aqueous humor’s depth in different anterior chamber sites and the 
unequal distribution of incident light I0, the light intensity I should be expressed as follows: 
 
2( ( ) ( )) ( , )
0 ( , ( , )) ( ) ( , ) ,
as dr I d r I r e
         
     (2) 
where r denotes the distance between incidence light positions on iris and pupil center, and χ 
(λ, r) denotes the distribution of light intensity I according to r. Taking the  logarithm of  
Eq. (2), we obtain 
  0 ln( ( , ( , ))) ln( ( )) ln( ( , )) 2( ( ) ( )) ( , ). as I d r I r d r                  (3) 
#136682 - $15.00 USD Received 15 Oct 2010; revised 8 Dec 2010; accepted 3 Jan 2011; published 5 Jan 2011
(C) 2011 OSA 1 February 2011 / Vol. 2,  No. 2 / BIOMEDICAL OPTICS EXPRESS  233 
Fig. 1. The structure of anterior chamber. An incident light beam I0 gets into the anterior 
chamber. After passing through the aqueous humor, the emergent light I is scattered back from 
the  iris.  Being  absorbed  twice  by  the  material  in  the  aqueous  humor,  the  emergent  light 
intensity I carries the information of material concentration. 
By subtracting the logarithm signals acquired from the two lights, we obtain 
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1 1 1
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2 2 2
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   (4) 
where  subscripts  1  and  2  denote  the  wavelength  392  nm  and  850  nm,  respectively.  The 
anterior chambers of humans and rabbits are relatively transparent between 300 and 1400 nm 
[18]. Since only a small amount of light scattering is present in the aqueous humor [18], the 
scattering  of  the  two  wavelengths  is  negligible  compared  to  that  of  the  absorption. 
Furthermore, as the absorption coefficient of the light with wavelength at 392 nm is far larger 
than that at 850 nm, the influence of the latter can be neglected. Therefore, the Eq. (4) can be 
reduced to 
 
01 1 1 1
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Taking the integral of Eq. (5), we obtain 
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where integral from r1 to r2 corresponds to the iris area. For each sample model, r1, r2 were 
chosen according to the iris area of the images captured by the CCD. For succinct expression 
and analysis, we define k = I (λ1, d (λ1, r))/I (λ2, d (λ2, r)), which denotes the ratio of the two 
wavelength signals directly acquired by the CCD. And we define 
 
2
1
11
22
( , ( , ))
ln( ) ,
( , ( , ))
r
r
I d r
S dr
I d r


    (7) 
as special area, which denotes the logarithm ratio of two wavelengths signals reflecting from 
the whole iris area. As will be explained below, the special area S has a linear relationship 
with the material concentration c in the aqueous humor. With the absorption cross section σa 
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of the absorbing material is calculated via [19] 
  1 () . a
a
c 
     (8) 
Combining Eq. (6), Eq. (7) and Eq. (8), we obtain 
  () , Sb c a
     (9) 
where 
 
2
1
01 1
0 2 2
() ( , )
(ln( ) ln( )) ,
( ) ( , )
r
r
I r
b dr
Ir
 
  
       (10) 
and 
 
2
1
1 2 ( , ) .
r
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Coefficients  a  and  b  are  defined  for  simplification  and  for  clear  appearance  of  the  final  
Eq. (9). The distribution of light intensity I according to r χ (λ, r) can be calculated by our 
verification experiment that is described latter in this manuscript. Thus we can obtain the 
exact value of b. The absorption cross section σa of the pure substance can be measured by 
traditional spectroscopy. The depth d can be measured with optical coherence tomography 
[20]. Therefore, coefficient a can be calculated. As a result, if we measure the special area S 
by our technique, the substance concentration c can be predicted. 
3. Materials and experimental setup 
In our experiment, Pirenoxine Sodium, which is a common kind of drug to treat cataract, was 
used to prove the feasibility of our approach. The Pirenoxine Sodium absorption spectrum 
was measured by a traditional UV spectrophotometer (DU 800, Beckman Coulter, US) and 
the result is shown in Fig. 2. It can be concluded from Fig. 2 that Pirenoxine Sodium has an 
absorption  peak  at  392  nm  where  the  absorption  of  water  is  very  low.  In  addition,  both 
Pirenoxine Sodium and water have very low absorption at 850 nm. According to the measured 
absorption spectrum, two different light sources, one centered within (392 nm) and the other 
centered outside (850 nm) of a Pirenoxine Sodium absorption band, were utilized to image the 
iris. 
 
Fig.  2.  The  absorption  spectrum  of  Pirenoxine  Sodium  measured  by  a  commercial  UV 
spectrophotometer. The concentration of measured Pirenoxine Sodium solution was 5.33 ppm. 
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Fig. 3. The schematic used in the experiment. 
Figure  3  shows  the  experiment  setup.  Two  light  sources  were  used  to  take  the  dual-
wavelength iris images. The center wavelength of one Light Emitting Diode (LED) was 392 
nm, the other was 850 nm. The bandwidth of 392 nm and 850 nm LED was 16 nm and 42 nm, 
respectively. After collimated lens, the two lights were coupled together by a beamsplitter 
(Edmund, Singapore). In order to use parallel light to image the whole iris, a beam expand 
system was introduced into this system. In addition, an obscured glass was used to eliminate 
the structure information of the light sources. For light source with wavelength at 392 nm and 
850  nm,  the  power  incident  on  the  cornea  was  measured  to  be  0.43  mW/cm
2  and  0.15 
mW/cm
2, respectively. The diffuse reflection light from iris was focused and detected by a 
CCD (Retiga EXi, Q-imaging, Canada). 
 
Fig. 4. The images of the paper under the illumination of both wavelengths’ light. 
A piece of white paper was used as the sample to verify whether the incident beam was 
parallel and uniform. The images of the paper under the illumination of both 392 nm and 850 
nm lights are shown in Fig. 4. From Fig. 4, we can see that the two wavelengths’ beam spots 
have nearly the same size and position. Moreover, the light intensity of each wavelength is 
almost the same as the radius increases. It can be concluded that the incident beams of both 
wavelengths were parallel and uniform. 
An eye model was developed to simulate the structure of the anterior chamber. The model 
included a hemisphere glass shell, the liquid inside and a piece of water proof paper fastened 
on  the  shell,  which  represented  the  cornea,  the  aqueous  humor  and  the  iris,  respectively. 
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experiment,  we  prepared  a  series  of  different  Pirenoxine  Sodium  water  solutions  at  the 
concentration of 0, 2, 4, 5, 6, 8, 10 ppm. 
Due to the similarity in sizes and structures between rabbit eyes and human eyes, a New 
Zealand rabbit was used in the in vivo experiment. Pelltobarbitalum Natricum was used to 
anesthetize the rabbit at the beginning of the experiment. The rabbit was totally anesthetized 
after around ten minutes. It was then tied on the sample stage and kept still throughout the 
entire experiment. In this in vivo experiment, the Pirenoxine Sodium was injected into the 
rabbit  anterior  chamber.  The  volume  of  the  rabbit  anterior  chamber  is  250  μL  [21].  The 
Pirenoxine Sodium solution at a concentration of 500 ppm served as the mother liquor in our 
experiment. We first injected 2 μL and then continued to inject 3 μL of the mother liquor into 
the anterior chamber. As a result, the Pirenoxine Sodium solution at concentrations of 4 ppm 
and  10  ppm  can  be  successively  obtained  in  the  anterior  chamber.  In  conclusion,  three 
different concentrations 0, 4, 10 ppm were detected in the in vivo experiment. 
4. Results 
4.1 ZEMAX experiment 
To verify the feasibility of this experiment, an analogy experiment was carried out with the 
ZEMAX@ software. A hemisphere model (with inner diameter of 24 mm, outer diameter of 
32 mm and a refractive index of 1.5 for cornea, a refractive index of 1.34 for aqueous humor) 
and an anterior chamber model (with front plane curvature radius of 7.8 mm, back plane 
curvature radius of 6.8 mm, plane radius of 11 mm and a refractive index of 1.377 for cornea, 
a refractive index of 1.3374 for aqueous humor, center depth of 3 mm for aqueous humor) 
were set up to simulate the experiment. Experiments were completed at wavelengths of 392 
nm and 850 nm in the two models, respectively. A total of 500,000,000 traced rays were used 
in  the  experiment.  A  ray  tracing  approach  was  employed  in  which  the  light  rays  were 
emanated in parallel from the source through the cornea and the aqueous humor. After being 
reflected by the iris, the light rays passed through the aqueous humor and the cornea again 
towards  a  focusing  lens,  and  eventually  were  detected  by  an  imaging  detector.  The 
simulations were completed by varying attenuate coefficients of the aqueous humor from 100 
percent to 10 percent, which correspond to Pirenoxine Sodium concentration between 0 ppm 
to 2.36 ppm. The attenuate coefficient was defined as the ratio of the light intensity after 
propagating through an optical path of 25 mm to its original value. The results of the two 
models  are  shown  in  Fig.  5.  It  illustrates  a  strong  linearity  between  special  area  S  and 
concentration c, which demonstrates the viability to calculate the drug concentration in the 
aqueous humor with our approach. 
 
Fig.  5.  The  stimulation  results  by  ZEMAX  software.  With  different  parameters  set  for 
hemisphere model and anterior chamber model, the relationship between specific area S and 
drug  concentration  c  changes.  Nevertheless,  the  linearity  of  S  and  c  is  strong  under  both 
models. 
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Figure 6 shows the original data recorded by the CCD. Here, as all the images satisfy the same 
regularity, we only show four different concentration liquids. The white dot near the center of 
each figure corresponds to the strong mirror reflecting signals from the cornea. Figure 6(a) 
and 6(b) illustrate that the light intensity distribution are uniform in the area of iris both with 
the  two  light  sources  if  there  are  no  absorption  substances.  In  other  pictures,  the  images 
recorded by 392 nm are darker in the middle part than their peripheral parts while there are no 
changes of the images recorded by 850 nm. Moreover, as the concentration increases, figures 
of light with wavelength at 392 nm become darker while the figures of light with wavelength 
at 850 nm almost stay the same. 
For each image in Fig. 6, we processed the data within the dashed circle, which is only 
shown in Fig. 6(a) for a clearer view. The circle was divided into 500 concentric rings with 
the same thickness. In each ring, we used the average intensity to calculate lnk, where lnk is 
the logarithm of the ratio of two wavelengths light intensities recorded by the CCD. Figure 7 
shows the relationship between lnk and r. There are significant differences between these 
curves with respect to different Pirenoxine Sodium concentrations. In Fig. 7, lnk decreases as 
Pirenoxine Sodium concentration increases with the same r. In addition, lnk increases as the r 
becomes larger. Only the pictures with r from 200 to 500 pixels in the CCD images were 
selected, which represent the iris’ situation. 
 
Fig. 6. Images of the anterior chamber under different Pirenoxine Sodium concentrations using 
two light sources with different wavelengths, one centered within the absorption band of the 
drug,  and  the  other  outside  the  absorption  band.  As  the  drug  concentration  increased,  the 
images of 392nm light source got darker, while the ones of 850nm light source maintained 
almost unchanged. (a) We used the dashed circle area to calculate drug concentration. 
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Fig. 7. Calculated lnk versus r under different Pirenoxine Sodium concentrations in the eye 
model experiment. As the concentration increases, the value of lnk decreases. 
Figure 8 shows the computed special area S. To increase the signal-to-noise ratio of these 
measurements, we averaged special area S calculated from Eq. (7) over 30 measurements. The 
linear fitting curve in the picture can be described as 
  8.324* 3.024, Sc     (12) 
where the correlation coefficient is 0.9989. The system sensitivity is defined as the measured 
value’s  responsiveness  to  the  characteristic  value.  The  sensitivity  of  system  can  thus  be 
expressed as 
  , S s c
      (13) 
where  ΔS  is  the  difference  of  S  (84.02  in  this  experiment),  and  Δc  is  the  concentration 
difference  (10ppm  in  this  experiment).  s  is  therefore  the  slope  of  Eq.  (12).  The  system 
sensitivity is 8.324. 
The system resolution is defined as 
  ,
c
cS
S




   (14) 
where δS is the standard variation of S. When the concentration is 6 ppm, the experiment gets 
the maximum standard deviation of S (δS = 5.4).The resolution is calculated as 0.6525 ppm, 
with the maximum δS. 
 
Fig.  8.  The  specific  area  S  versus  concentration  of  Pirenoxine  Sodium  in  the  eye  model 
experiment. Data were averaged out of 30 measurements, and the error bars correspond to the 
standard deviation. The resolution was 0.6525 ppm. 
#136682 - $15.00 USD Received 15 Oct 2010; revised 8 Dec 2010; accepted 3 Jan 2011; published 5 Jan 2011
(C) 2011 OSA 1 February 2011 / Vol. 2,  No. 2 / BIOMEDICAL OPTICS EXPRESS  2394.3 In vivo experiment 
Figure 9 shows the original pictures from the CCD in the in vivo experiment. As mentioned 
earlier, the white areas correspond to the mirror reflecting signals from cornea. If there were 
no absorption substances, the light intensity distributions are uniform in the area of iris in the 
images.  When  Pirenoxine  Sodium  concentration  increases,  the  images  obtained  with  the 
wavelength at 392 nm become darker while the ones at 850 nm remain almost unchanged. 
 
Fig. 9. Rabbit eye Images pictured by CCD with two wavelengths under different Pirenoxine 
Sodium concentrations. 
The analysis of pictures from CCD is similar to the model experiments. Corresponding to 
real iris location and neglecting the pupil image, pictures with r from 140 to 300 from the 
CCD  were  selected  in  the  in  vivo  experiment.  The  special  area  S  was  averaged  over  30 
measurements and shown in Fig. 10. The results show that the concentration c and the specific 
area S still meet the linearity relationship. It shows that at least 4 ppm Pirenoxine Sodium 
concentration can be distinguished. 
 
Fig.  10.  The  specific  area  S  versus  concentration  of  Pirenoxine  Sodium  in  the  in  vivo 
experiment. Data are the average of 30 measurements, and the error bars correspond to the 
standard deviation. 
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To illustrate the feasibility of this method, the influence resulting from the cornea should be 
taken into account. As explained before, we only need to analyze the change of absorption 
coefficient of light with wavelength at 392 nm. In the model experiment, with a hemisphere 
glass in place of the cornea, the absorption of the glass stays unchanged. In this situation, the 
influence of the cornea can be included in the coefficient b in Eq. (10). There would be no 
change in the experiment results. In the in vivo experiment, the material would penetrate into 
the cornea after injected into the anterior chamber. As a result, the substance concentration in 
the cornea would have a stable correlation with its concentration in the aqueous humor. Based 
on Eq. (9), the relationship between S and c remains the same, except a little change in the 
coefficient a: 
 
22
11
11 ( ( , ) ( , ) ),
rr
a rr a d r dr z r dr            (15) 
where  z  (λ1,  r)  denotes  the  depth  of  the  cornea,  and  η  denotes  the  ratio  of  absorption 
coefficient between the cornea and the aqueous humor. Therefore, taking the influence of the 
cornea into account would bring a change of slope in the final fit between the special area S 
and  the  concentration  c  without  changing  their  linear  relationship.  We  are  still  able  to 
calculate the material concentration in the anterior chamber via the signals detected by the 
CCD. 
In our experiment, the iris was treated as a natural reflector. The iris exhibits the same 
reflectance distribution at the two wavelengths of 392 nm and 850 nm that we utilized [22]. 
The only difference is reflectance intensity ratio at the two wavelengths for irides of different 
color. This influence can be included in the coefficient b in Eq. (10). Thus, considering the 
reflection and scattering properties of the iris for 392 nm and 850 nm would lead to no change 
in the experiment results. 
The  influences  of  other  chemical  materials  in  the  aqueous  humor  are  not  taken  into 
account in our experiment. We verify that our technique can monitor the Pirenoxine Sodium 
concentration in aqueous humor. Two possible methods can be considered in the future to 
reduce the influence of other materials. One is multivariate calibration techniques [23–25]; the 
other is to use a closed-loop system [26]. Both of them have been demonstrated to be able to 
compensate for the interference due to other materials potentially. 
The flowing status of liquid also plays a significant role on the measurement of material 
concentration  in  the  solution.  The  light  intensities  vary  as  the  flowing  status  changes. 
Generally, the solution becomes static in two minutes after every change of the liquid based 
on the observation in the experiment. Since the production rate of aqueous humor is about 3.1 
μL/min in the daytime [27], a dynamic equilibrium can be maintained. As a result, the change 
of flowing status as well as the errors from it can be ignored when the substance concentration 
variation is induced by its changes in blood. 
In order to reduce the errors in the experiment, the temperature influence should also be 
considered  [28].  Since  the  absorption  coefficient  changes  if  the  temperature  varies,  the 
experiment should be carried out at the same temperature. The most critical element is that the 
temperature of samples should remain the same when the experiments are processed. As the 
aqueous  humor  is  bounded  by  the  cornea  and  iris,  which  are  located  in  the  eyes,  the 
temperature stays almost constant. Compared to the external bodies, such as skin, and earlobe, 
which  are  frequently  used  in  current  material  concentration  detection,  the  changes  of 
temperature are much smaller. 
In this experiment, an obscured glass was utilized to eliminate the influence resulting from 
the structure of light sources and to achieve uniform light. In the future experiments, a Kohler 
illumination system, which can obtain the uniform light more effectively, can be utilized to 
improve the resolution and reduce the errors in the detection. 
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We  developed  a  dual-wavelength  iris  imaging  technology  to  monitor  Pirenoxine  Sodium 
concentration in the aqueous humor. We proved that the light intensities with wavelength at 
392 nm declined sharply after passing through the aqueous humor with Pirenoxine Sodium 
while the intensities at 850 nm remained almost the same. Furthermore, as Pirenoxine Sodium 
concentration  increased,  the  light  intensities  with  wavelength  at  392  nm  decreased 
significantly  whereas  the  intensities  at  850  nm  did  not  change  much.  The  measurement 
resolution we achieved in the eye model experiment was 0.6525 ppm. Meanwhile, at least 4 
ppm can be differentiated in the in vivo experiment using a New Zealand rabbit. These results 
proved  the  feasibility  of  this  method  to  monitor  Pirenoxine  Sodium  concentration  in  the 
aqueous humor and its potential ability to monitor other materials’ concentration as well. 
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